InvestorsHub Logo
Followers 6
Posts 225
Boards Moderated 0
Alias Born 09/05/2013

Re: None

Thursday, 09/12/2013 5:17:15 PM

Thursday, September 12, 2013 5:17:15 PM

Post# of 344
Dr Frost play BZNE could double like OPK
Biozone (BZNE) is a classic Dr. Phillip Frost play to help the human body and donate his proceeds as a part of his estate to humankind through his signed Bill & Melinda Gates Foundation "Giving Pledge." Dr. Frost is a Forbes-listed billionaire and humanitarian, responsible for countless discoveries to lessen human suffering through TEVA, IVAX, Opko Health, the Mayo Clinic, Schering-Plough, and his donations of millions of dollars to museums and research institutions, especially near he lives in south Florida, Miami area.

In case you've been living under a rock Dr. Frost is the hottest biotech small-cap investor in the world right now. He has added $1.1+ billion to his personal net worth this year. His main company, Opko (OPK) has doubled this year. Other Dr. Frost stocks that have doubled this year include MSLP, IDI, SFES, NIMU. There is no other investor more heavily followed in biotech. He has been on CNBC, received Jim Cramer's explicit approval.

BZNE is a real company, generated $12 million in revenue last year, NOT a shell. Large contract manufacturing facility in California that provides cash flow.

The reason Dr. Frost invested is because of its drug delivery molecules called QuSomes. QuSomes are not drugs. Completely non-toxic, inert substances. They just increase the water solubility of other ingredients. BioZone's (BZNE) QuSomes help to increase the solubility of drugs, such as drugs that Dr. Frost wants to dissolve in water at his Opko company.

BZNE QuSomes can help dissolve almost any drug in water. Higher water solubility = higher bioavailability = higher drug effectiveness in the human body. There is no better solvent than QuSomes. That's why BioZone (BZNE) makes so many millions in current revenue from QuSomes, and Dr. Frost has big plans for making many, many, many more millions through his power at Opko, Teva, and other big pharma.

Right now BZNE is trading light volume just above Dr. Frost's strike price for his warrants, which is EXACTLY what all of his other stocks did for weeks/months until they doubled or tripled: SFES, NIMU, IDI, WPHM, ROX. Dr. Frost is the top biotech investor of 2013, has appeared on CNBC and has feature articles being written about him in Barron's, Wall Street Journal, Bloomberg, and elsewhere. Long BZNE.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.